Key result
Mitral valve surgery in patients with mitral regurgitation and LVEF <30% resulted in a 5-year survival rate of 77% and improved mean ejection fraction from 23.1% to 36%.
Why the study?
Does isolated mitral valve surgery improve outcomes in patients with mitral regurgitation and severe left ventricular dysfunction (LVEF <30%)?
Cohort (n=31)
Does isolated mitral valve surgery improve outcomes in patients with mitral regurgitation and severe left ventricular dysfunction (LVEF <30%)?
Mitral valve surgery in selected patients with severe left ventricular dysfunction and mitral regurgitation is associated with acceptable survival and significant improvements in symptoms and ejection fraction.
Answers are grounded in this paper and cite their sources.
May support surgery in selected patients with severe LV dysfunction and MR; leaves open randomized confirmation of benefit.
BACKGROUND: Mitral valve surgery for the correction of secondary mitral valve regurgitation (MR) in cardiomyopathy is associated with a poor outcome. Numerous studies have identified a severe left ventricular dysfunction as an indicator for a poor prognosis. The aim of the study was to asses the follow-up after mitral valve surgery and severe left ventricular dysfunction. METHODS: Between 1994 and 2000, 31 patients with mitral regurgitation and a left ventricular ejection fraction of below thirty percent undergoing isolated repair (n = 16) or replacement (n = 15) were investigated. All patients received maximal drug therapy. Twenty-one patients were New York Heart Association (NYHA) class III and 10 were class IV. Follow-up with echocardiography, ECG, and chest x-ray was performed in 87 % of the survivors. The mean duration of follow-up was 39 +/- 16 months. RESULTS: The mean duration of ICU and hospital stay was 3.6 +/- 2.1 days and 8.1 +/- 5.4 days, respectively. The 1-, 2-, and 5-year survival rates were 91 %, 84 %, and 77 %, respectively. NYHA class improved from 3.3 +/- 0.8 to 2.1 +/- 0.7 at follow-up (p < 0.01). The ejection fraction improved from 23.1 +/- 6.6 % to 36 +/- 6.8 % at follow-up (p < 0.02). Freedom from readmission for heart failure was 85 %, 79 %, and 68 % at 1-, 2-, and 5 years, respectively. CONCLUSIONS: Mitral valve surgery improves left ventricular function and reduces heart failure severity in patients with MR and cardiomyopathy. High-risk mitral valve surgery may be an alternative to heart transplantation in selected patients.
No takes yet. Share an insight, caveat, or question.
Rothenburger et al. (2002) conducted a cohort in Mitral regurgitation and severe left ventricular dysfunction (n=31). Mitral valve surgery was evaluated on 5-year survival rate. Mitral valve surgery in patients with mitral regurgitation and LVEF <30% resulted in a 5-year survival rate of 77% and improved mean ejection fraction from 23.1% to 36%.
Synapse has enriched 10 related papers. Consider them for comparative context: